Amid the global battle against cancer, Europe stands as a beacon of progress in the field of cancer treatment. Each passing year witnesses significant strides, reflecting a commitment to innovation and collaboration. While challenges persist, the collective efforts of researchers, clinicians, and policymakers have propelled Europe to the forefront of advancements in cancer care.
Greece, nestled within the broader European context, has been forging its path in the realm of cancer treatment with notable dedication and progress. The country’s cancer strategy, intricately woven into the fabric of the European Beating Cancer Plan, reflects a commitment to fostering innovation and accessibility in healthcare.Ā
Within this context, Economist Impact is organising the Fourth Annual Cancer Summit, entitled āGreeceās determination to fight cancer: The achievements-The obstacles-The European realityā. This year’s summit, organised under the scientific auspices of the Hellenic Society of Medical Oncology and the auspices of the Hellenic Cancer Federation, provides a unique platform for experts, policymakers and healthcare professionals to collectively assess the nation’s achievements, share insights, and collaboratively shape the trajectory of cancer treatment in Greece.
Ā
Under the scientific auspices ofĀ Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Under the auspices ofĀ Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Supported byĀ Ā Ā Ā
Ā Ā
Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā
Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā Ā 
Alternate minister
Professor of medical oncology
Secretary-general for strategic planning
Assistant professor in health economics and health technology assessment
Īedical oncologist, director of oncology clinic
Medical oncologist
Head, HTA Committee, Hellenic Ministry of Health, Associate professor of pediatrics ā adolescent medicine
Chief executive officer
GREECEāS PROGRESS & FUTURE IN THE FIGHT AGAINST CANCER
ā Greeceās strategy to fight cancer
ā HeSMO reflections on cancer priorities
ā The need for a national cancer plan
ā Cancer āmovesā beyond
Adonis Georgiadis, minister of health, Greece
Zenia Saridaki ā Zoras, medical oncologist, president of the BoD, Hellenic Society of Medical Oncology (HeSMO), director, 1st Oncology Dept., Metropolitan Hospital Athens & Asklepios Diagnosis Crete
George Kapetanakis, president, Hellenic Cancer Federation (ELLOK)Ā
Mike Holmes, vice-president, global medical & scientific affairs oncology therapeutic area, MSD Global
Andreas Charalambous, past-president, European Cancer Organisation, fmr president, European Oncology Nursing Society, professor oncology and palliative care
ā Public health and cancer prevention policies in Greece
ā Social inequalities in public policy making
ā Addressing the issue of inequalities in lung cancer
ā The establishment of cancer-free cities
ā The value of investing in patient health literacy
Eirini Agapidaki, alternate minister, Ministry of health, Greece
Yannis Tountas, emeritus professor of social medicine, National and Kapodistrian University of Athens, director, Institute of Social and Preventive Medicine (ISPM)
Andriani Charpidou, pulmonologist, head of clinical trials bureau, 3rd Dept. of Internal Medicine and Laboratory Medical School, National and Kapodistrian University of Athens, "Sotiria" Hospital
Michail Nikolaou, medical oncologist, General Anticancer - Oncology Hospital of Athens āSaint Savvasā, vice-president of the BoD, HeSMO
Vasiliki-Rafaela Vakouftsi, president, Greek Patientsā Association (recorded message)
Commentators:
Nikolaos Tsoukalas, medical oncologist, director, Oncology Dept., 401 General Military Hospital, General secretary of the BoD, HeSMO
Ioannis Boukovinas, medical oncologist, head of BIOCLINIC Oncology Unit, Thessaloniki
Moderator:
Mary Bussell, founder, TriMar Strategies
ā The value of population screening programs
ā The importance of medical awareness on early identification of cancer care patient in primary care services
ā The role of referral networks between specialties
Anastasios Boutis, consultant medical oncologist, director, 3rd Med. Oncology Dept., "Theagenio" Anticancer Hospital of Thessaloniki, treasurer of the BoD, HeSMO
Christos Lionis, emeritus professor, general practice and primary health care, School of Medicine, University of Crete (via connection)
Sofia Agelaki, professor of medical oncology University General Hospital of Heraklion, Laboratory of Translational Oncology, Faculty of Medicine, University of Crete
Commentators:
Dimitris Nikas, managing director, Medtronic Hellas
Stylianos Loukides, president, Hellenic Thoracic Society, Professor of Respiratory Medicine, National Kapodistrian University of Athens - Medical School - Attiko University Hospital
Michalis Karamouzis, medical oncologist, professor, medical school, National and Kapodistrian University of Athens
ā The benefits of early management in clinical outcomes
ā The role of biomarkers & new technologies in personalized cancer careĀ
ā The impact of EU HTA regulation in cancer innovation
ā Ensuring sustainable financing for cancer innovation
ā The need of investing in early cancer care management
Michalis Liontos, medical oncologist, assistant professor of oncology, department of clinical therapeutics, National and Kapodistrian University of Athens, member of the BoD, HeSMOĀ
Eleni Kourea, professor of pathology, University of Patras, president, Pathology Society
Flora Bacopoulou, head, HTA Committee, Hellenic Ministry of Health, Associate professor of pediatrics ā adolescent medicine, National and Kapodistrian University of Athens
Nandia Gogozotou, non-executive president, EOPYY, president, Drug Price Negotiation Committee
Kostas Athanasakis, assistant professor in health economics and health technology assessment, Department of Public Health Policy, University of West Attica
Commentator:
Ilias Athanasiadis, medical oncologist, director of oncology clinic, Mitera Hospital
Moderator:
Mary Bussell, founder, TriMar Strategies
ā The reforms of national health system in Greece
ā Transforming hospitals into comprehensive cancer care centers
ā The benefit of holistic care in clinical outcomes
ā The need for introduction of multi-disciplinary teams in the cancer care delivery model
ā The benefit of comprehensive cancer centers in cancer patient journey
ā The value of RWE on the impact of early diagnosis in cancer
Marios Themistocleous, deputy minister of health, Greece (via connection)
Olga Balaoura, president of the board & CEO, General Anticancer - Oncology Hospital of Athens āSaint Savvasā
Athina Christopoulou, medical oncologist, head, Department of Internal Medicine,Ā
Division of Clinical Oncology, St. Andrewās General Hospital of Patra, special secretary of the BoD, HeSMO
Dimitrios Papageorgiou, assistant professor, University of Peloponnese, president, Hellenic Oncology Nursing Society
Paraskevi Michalopoulou, president, Ā Hellenic Association of Women with Breast Cancer āAlma Zoisā, vice-president, Hellenic Cancer Federation (ELLOK)
Thanassis Lopatatzidis, commercial executive director, AffideaĀ Ā
Commentator:
Eleni Galani, director, 2nd Oncology Clinic, Metropolitan Hospital
Vassilis Balanis, chief executive officer, National Agency for Quality Assurance in Health (ODIPY)
ā The national strategy for cancer: the way forward
ā How AI contributes to healthcare
ā The role of AI in cancer
ā Digital support of lung cancer patients
ā The future of clinical trials in cancer
Lilian Venetia Vildiridi, secretary-general for health services, Ministry of Health, Greece
Anastasia Krithara, associate researcher, Institute of Informatics & Telecommunications, NCSR Demokritos, general secretary, Hellenic Artificial Intelligence Society
Nikos Iosif, president, Human Health Intelligence Organization, CEO, Brains I.C.S.
Thanos Kosmidis, co-founder & CEO, Care Across
Christian Hosius, senior clinical director, MSD European Clinical Development
Commentators:
Ioannis Souglakos, medical oncologist, professor of medical oncology, Faculty of Medicine, University of Crete
Emmanouil Saloustros, associate professor of oncology, University of Thessaly,Ā
member of the BoD, HeSMO (via connection)
Helena Linardou, medical oncologist, director, 4th Oncology, Dept. & Comprehensive
Clinical Trials Center, Metropolitan HospitalĀ
ā Ensuring patientsā access to innovative therapies
ā Beyond cancer: How to improve survivorsā experience
ā The value of home care and palliative services for cancer patients
ā The value of digitalization of cancer care
ā The importance of incorporating patientsā voice in cancer policy planning
Aris Angelis, secretary-general for strategic planning, Ministry of Health, Greece
Amanda Psyrri, professor of medical oncology, National Kapodistrian University of Athens, chairman of internal medicine, Attikon University Hospital
Maria Avgoustidou, medical oncologist, Athens Medical Group
Niki Tsouma, president of the board and CEO, IDIKA, e-Government Center forĀ
Social Security Services
Dafni Kaitelidou, president, National Agency for Quality Assurance in Health (ODIPY)
Commentator:
Paris Kosmidis, head of the second Medical Oncology Department, Hygeia Hospital,Ā
former president, ESMO
Athanasios Kotsakis, professor of Medical Oncology, University of Thessaly Medical School, Director, University Oncology Clinic, University Hospital of Larissa (via connection)
ā Cancer priorities in Greece
Zenia Saridaki ā Zoras, medical oncologist, president of the BoD, Hellenic Society of Medical Oncology (HeSMO), director, 1st Oncology Dept., Metropolitan Hospital Athens & Ā Asklepios Diagnosis Crete
George Kapetanakis, president, Hellenic Cancer Federation (ELLOK)Ā
ā¬1.800 tax/VAT excl.
ā¬2.200 tax/VAT excl.
ā¬7.500 tax/VAT excl./ table (8 seats)
Escape in a haven of relaxation and grandeur by the azure of the sea, delve in the pleasures of luxury and experience the epitome of indulgence in the dreamiest island-like resort of the Athenian Riviera. Nuzzled in a 72-acre private peninsula in the Athenian Riviera with stunning views to the Saronic Gulf, the 5 star Grand Resort Lagonissi exceeds all expectations of a luxury sea front summer resort.
Grand Resort Lagonissi 40th km Athens Sounion, Lagonissi Attica, Athens
General information
Phone: (+30) 210 94 08 750
info@hazliseconomist.com
Sponsorships & partnerships
Clarine Kalogeraki
Phone: (+30) 210 94 08 750
clarine@hazliseconomist.com
Commercial department
Konstantinos Sarlas
Phone: (+30) 210 94 08 750 (ext. 210)
ksarlas@hazliseconomist.com
Business development, marketing & sales
Katerina Zacharakopoulou
Phone: (+30) 210 94 08 750
katerina.zach@hazliseconomist.com
Press office
Phone: (+30) 210 94 08 750
press@hazliseconomist.com